1. Alyea EP, Anderson KC: Allotransplants for mutliple myeloma, in DeVita VT, Hellman SH, Rosenberg SA (eds): Cancer Principles and Practice of Oncology (ed 6). Philadelphia, PA, Lippincott Williams and Wilkins (in press)
2. Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant;Alyea;Blood,1998
3. Alyea EP, Weller E, Schlossman RL, et al: T cell depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: Reduced transplant-related toxicity with preservation of graft versus myeloma effect. Blood (in press)
4. Anderson K: Novel biologically-based therapies for myeloma, in Dicke KA, Keating A (eds): Autologous Marrow and Blood Transplantation. Charlottesville, VA, Carden Jennings (in press)
5. Monoclonal antibody purged bone marrow transplantation therapy for multiple myeloma;Anderson;Blood,1993